Alpha Tau Medical Ltd (DRTS) — Capital Reinvestment Ratio

Latest as of June 2021: 0.23x

Alpha Tau Medical Ltd (DRTS) has a Capital Reinvestment Ratio of 0.23x as of June 2021, meaning it reinvests 0% of its operating cash flow ($2.65 Million) in capital expenditures ($609.00K). Check DRTS tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.23x
Capex / Operating Cash Flow

Operating Cash Flow

$2.65 Million
USD

Capital Expenditures

$609.00K
USD

Data as of

Jun 2021
Most recent filing

Annual Capital Reinvestment Ratio for Alpha Tau Medical Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Alpha Tau Medical Ltd from None to None. See Alpha Tau Medical Ltd (DRTS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow